| |
| |
|
| Insider
Information: |
Miller Edward |
| Relationship: |
|
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
239,780 |
|
|
Indirect Shares
|
288,799 |
|
|
| Direct
Value |
$3,685,253 |
|
|
|
Indirect Value
|
$217,321 |
|
|
| Total
Shares |
528,579 |
|
|
| Total
Value |
$3,902,574 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
10
|
|
Stock
price went up :
|
0
|
7
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.3
|
| Percentage
Gain/Loss : |
0.0%
|
 -6.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
SVP, Chief Compliance ... |
2017-02-28 |
19,284 |
2014-09-08 |
0 |
Premium* |
|
|
Allovir Inc |
ALVR |
|
2024-05-17 |
220,496 |
2024-05-17 |
288,799 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
39 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALVR |
Allovir Inc |
General CounselOfficer |
• – – |
2020-07-29 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
124,538 |
|
- |
|
| ALVR |
Allovir Inc |
General CounselOfficer |
• – – |
2020-07-29 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
207,565 |
|
- |
|
| ALVR |
Allovir Inc |
General CounselOfficer |
• – – |
2020-07-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
332,103 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Chief Compliance Officer |
• – – |
2014-09-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Chief Compliance Officer |
• – – |
2015-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
3,830 |
6,830 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Chief Compliance Officer |
• – – |
2015-09-09 |
4 |
S |
$179.55 |
$65,715 |
D/D |
(366) |
6,464 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Chief Compliance Officer |
• – – |
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
8,802 |
15,266 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Chief Compliance Officer |
• – – |
2016-02-05 |
4 |
S |
$141.23 |
$150,314 |
D/D |
(1,051) |
14,215 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Chief Compliance Officer |
• – – |
2016-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
17,215 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Chief Compliance Officer |
• – – |
2016-02-29 |
4 |
S |
$138.91 |
$45,701 |
D/D |
(329) |
16,886 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Chief Compliance Officer |
• – – |
2016-09-09 |
4 |
S |
$128.32 |
$47,093 |
D/D |
(367) |
16,519 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Chief Compliance Officer |
• – – |
2017-02-27 |
4 |
S |
$131.20 |
$34,112 |
D/D |
(260) |
15,214 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Chief Compliance Officer |
• – – |
2017-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
4,400 |
19,284 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Chief Compliance Officer |
• – – |
2017-02-28 |
4 |
S |
$131.70 |
$43,461 |
D/D |
(330) |
14,884 |
0 |
- |
|
39 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
